Sign up to save your podcasts
Or
Share The C-Suite: How Biotech Improves the Standard of Care of Patients
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The C-Suite: How Biotech Improves the Standard of Care of Patients
Thought Leader: Brad Thompson, Ph.D., Chairman, President and CEO, Oncolytics Biotech In this episode, Dr. Thompson talks about how biotech is making improvements in the standard of care, and the impact of Pharma 3.0. He also talks about his own experience taking REOLYSIN® through the drug development process, the genesis of Oncolytics Biotech, and shares some insights for biotech entrepreneurs. Play Podcast For more information on how you can be featured in a podcast, contact Dan Limbach at [email protected] or call him at (847) 594-0157.
View all episodes
By Daniel LimbachThought Leader: Brad Thompson, Ph.D., Chairman, President and CEO, Oncolytics Biotech In this episode, Dr. Thompson talks about how biotech is making improvements in the standard of care, and the impact of Pharma 3.0. He also talks about his own experience taking REOLYSIN® through the drug development process, the genesis of Oncolytics Biotech, and shares some insights for biotech entrepreneurs. Play Podcast For more information on how you can be featured in a podcast, contact Dan Limbach at [email protected] or call him at (847) 594-0157.